First-generation structure-activity relationship studies of 2,3,4,9-tetrahydro-1H-carbazol-1-amines as CpxA phosphatase inhibitors.

Antibacterial CpxRA Drug discovery Efflux Medicinal chemistry Permeability Sensory kinase Two-component system

Journal

Bioorganic & medicinal chemistry letters
ISSN: 1464-3405
Titre abrégé: Bioorg Med Chem Lett
Pays: England
ID NLM: 9107377

Informations de publication

Date de publication:
15 07 2019
Historique:
received: 03 03 2019
revised: 02 05 2019
accepted: 03 05 2019
pubmed: 21 5 2019
medline: 10 9 2020
entrez: 21 5 2019
Statut: ppublish

Résumé

Genetic activation of the bacterial two-component signal transduction system, CpxRA, abolishes the virulence of a number of pathogens in human and murine infection models. Recently, 2,3,4,9-tetrahydro-1H-carbazol-1-amines were shown to activate the CpxRA system by inhibiting the phosphatase activity of CpxA. Herein we report the initial structure-activity relationships of this scaffold by focusing on three approaches 1) A-ring substitution, 2) B-ring deconstruction to provide N-arylated amino acid derivatives, and 3) C-ring elimination to give 2-ethylamino substituted indoles. These studies demonstrate that the A-ring is amenable to functionalization and provides a promising avenue for continued optimization of this chemotype. Further investigations revealed that the C-ring is not necessary for activity, although it likely provides conformational constraint that is beneficial to potency, and that the (R) stereochemistry is required at the primary amine. Simplification of the scaffold through deconstruction of the B-ring led to inactive compounds, highlighting the importance of the indole core. A new lead compound 26 was identified, which manifests a ∼30-fold improvement in CpxA phosphatase inhibition over the initial hit. Comparison of amino and des-amino derivatives in bacterial strains differing in membrane permeability and efflux capabilities demonstrate that the amine is required not only for target engagement but also for permeation and accumulation in Escherichia coli.

Identifiants

pubmed: 31104993
pii: S0960-894X(19)30289-6
doi: 10.1016/j.bmcl.2019.05.003
pmc: PMC6594187
mid: NIHMS1529824
pii:
doi:

Substances chimiques

2,3,4,9-tetrahydro-1H-carbazol-1-amine 0
Carbazoles 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1836-1841

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI136795
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA207288
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001108
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Références

Br J Pharmacol. 2007 Dec;152(8):1147-54
pubmed: 17704820
J Bacteriol. 1997 Dec;179(24):7724-33
pubmed: 9401031
Antimicrob Agents Chemother. 2016 Nov 21;60(12):7372-7381
pubmed: 27697764
Antimicrob Agents Chemother. 2015 Jul;59(7):3789-99
pubmed: 25870061
FEMS Microbiol Lett. 1999 Sep 1;178(1):169-75
pubmed: 10483736
Curr Opin Microbiol. 2010 Apr;13(2):232-9
pubmed: 20138000
Infect Immun. 2018 Feb 20;86(3):
pubmed: 29311237
Clin Infect Dis. 2004 May 1;38(9):1279-86
pubmed: 15127341
J Biol Chem. 2002 Jul 19;277(29):26652-61
pubmed: 11953442
Trends Pharmacol Sci. 2010 Nov;31(11):509-15
pubmed: 20843562
Nat Rev Drug Discov. 2010 Feb;9(2):117-28
pubmed: 20081869
Br J Pharmacol. 2011 May;163(1):184-94
pubmed: 21323894
Nature. 2017 May 18;545(7654):299-304
pubmed: 28489819
Infect Immun. 2017 Aug 18;85(9):
pubmed: 28652307
EMBO J. 1997 Nov 3;16(21):6394-406
pubmed: 9351822
Infect Immun. 2004 Aug;72(8):4654-61
pubmed: 15271926
Clin Infect Dis. 2009 Jan 1;48(1):1-12
pubmed: 19035777
Infect Immun. 2010 Sep;78(9):3898-904
pubmed: 20605985
Curr Opin Cell Biol. 2009 Apr;21(2):325-30
pubmed: 19246185
Annu Rev Biochem. 2000;69:183-215
pubmed: 10966457

Auteurs

Yangxiong Li (Y)

Institute for Natural Products Applications and Research Technologies, Norman, OK 73019-5251, United States; Department of Chemistry & Biochemistry, Stephenson Life Sciences Research Center, Norman, OK 73019-5251, United States.

Jessi J Gardner (JJ)

Institute for Natural Products Applications and Research Technologies, Norman, OK 73019-5251, United States; Department of Chemistry & Biochemistry, Stephenson Life Sciences Research Center, Norman, OK 73019-5251, United States.

Katherine R Fortney (KR)

Departments of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, United States.

Inga V Leus (IV)

Department of Chemistry & Biochemistry, Stephenson Life Sciences Research Center, Norman, OK 73019-5251, United States.

Vincent Bonifay (V)

Department of Chemistry & Biochemistry, Stephenson Life Sciences Research Center, Norman, OK 73019-5251, United States.

Helen I Zgurskaya (HI)

Department of Chemistry & Biochemistry, Stephenson Life Sciences Research Center, Norman, OK 73019-5251, United States.

Alexandre A Pletnev (AA)

Department of Chemistry, Dartmouth College, Hanover New Hampshire, 03755, United States.

Sheng Zhang (S)

Biochemistry, Indiana University School of Medicine, Indianapolis, IN 46202, United States.

Zhong-Yin Zhang (ZY)

Biochemistry, Indiana University School of Medicine, Indianapolis, IN 46202, United States; Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, United States; The Institute for Drug Discovery, Purdue University, West Lafayette, IN 47907, United States.

Gordon W Gribble (GW)

Department of Chemistry, Dartmouth College, Hanover New Hampshire, 03755, United States.

Stanley M Spinola (SM)

Departments of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, United States; Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, United States; Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, United States.

Adam S Duerfeldt (AS)

Institute for Natural Products Applications and Research Technologies, Norman, OK 73019-5251, United States; Department of Chemistry & Biochemistry, Stephenson Life Sciences Research Center, Norman, OK 73019-5251, United States. Electronic address: adam.duerfeldt@ou.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH